Medical Devices
Preclinical Imaging Market

Preclinical Imaging Market Size, Share, Growth, and Regional Forecast, 2025 - 2032

Preclinical Imaging Market By Product (Imaging Systems, Reagents, Software and Services), Modality, Application, End-user and Regional Analysis for 2025 - 2032

ID: PMRREP34717

July 2025

198 Pages

Author : Abhijeet Surwase

Healthcare

Preview Segmentation

Market Dynamics

Drivers - Rising adoption of multimodal imaging for comprehensive and correlated biological data acquisition

The growing need for detailed and multidimensional insight into disease mechanisms has accelerated the adoption of multimodal imaging in preclinical research. Innovations in hybrid imaging systems such as micro-CT or micro-MRI paired with functional modalities such as micro-PET or micro-SPECT is enabling researchers to gather high-resolution anatomical data alongside sensitive functional information. This integrated approach allows more accurate and comprehensive understanding of pathophysiological processes, particularly in areas like oncology, cardiology, neurology, and infectious diseases.

The growing burden of chronic diseases is raising the demand for new therapeutics, fuelling preclinical drug trials and imaging studies. Additionally, the expansion of contract research organizations (CROs) and improved access to advance in-vivo imaging technologies have made multimodal imaging more accessible to pharmaceutical companies and research institutions. These systems not only enhance data quality and reduce study duration but also support more efficient evaluation of novel drug candidates. These advancements are significantly contributing to the growth and diversification of the global preclinical imaging market.

Restraint - The high cost of advanced imaging systems limits adoption by small research facilities

The adoption of advanced preclinical imaging systems remains a significant challenge for smaller research facilities due to high upfront costs, ongoing maintenance, and operational expenses. These systems often equipped with multimodal capabilities require not only substantial financial investment but also specialized infrastructure, which many smaller institutions lack.

Additionally, the operation of sophisticated equipment demands skilled personnel, yet there is a notable shortage of trained professionals in the field. The situation is further compounded by strict regulatory protocols and complex animal testing requirements, which can delay research timelines and increase costs.

Animal rights advocacy and the shift toward non-invasive or alternative testing methods are also influencing institutions to reconsider investments in traditional preclinical imaging setups. These financial and logistical barriers continue to restrain broader access and adoption, especially among smaller entities, thereby limiting the overall expansion of the preclinical imaging market.

Opportunity - Increasing outsourcing opportunities for preclinical imaging services due to expanding CRO sector

The increasing complexity and high costs associated with preclinical research have encouraged pharmaceutical and biotechnology companies to outsource imaging services to specialized Contract Research Organizations (CROs). This approach allows access to advanced imaging technologies and expert analysis without heavy upfront investments in infrastructure or personnel.

The expanding CRO sector benefits from continuous innovations such as high-throughput screening, advanced imaging modalities, and computational modelling, which enhance research efficiency and data quality. Many regions are witnessing increased investments in R&D, supporting the adoption of innovative preclinical imaging solutions through CRO partnerships.

As companies focus on accelerating drug discovery and reducing timelines, outsourcing preclinical imaging to experienced CROs provides a cost-effective, flexible solution. This growing collaboration between pharmaceutical firms and CROs represents a significant opportunity driving the expansion of the global preclinical imaging market.

Get Your CustomizationGet Your Customization

Category-wise Analysis

Product Insights

Imaging systems are projected to hold the dominant position within the global market in 2025 due to their critical role in generating high-resolution, real-time anatomical and functional data essential for drug discovery. Compared to reagents, software, and services, imaging systems represent the foundational technology that enables detailed visualization of biological processes in-vivo. Advances in hybrid and multimodal imaging platforms further boost their demand. While reagents and software support data analysis and enhancement, the initial acquisition of precise imaging data relies heavily on sophisticated imaging hardware, making these systems indispensable and driving their market dominance.

Modality Insights

The optical imaging segment is expected to hold a significant revenue share of 19.0% in the preclinical imaging market in 2025. This is largely due to its extensive use in small animal imaging and new drug discovery projects. Its popularity stems from being cost-effective, non-invasive, and capable of real-time imaging, which facilitates monitoring disease progression and drug efficacy.

Optical imaging techniques such as bioluminescence and fluorescence are non-invasive and provide detailed molecular and cellular insights with improved sensitivity and resolution. Compared to modalities such as MRI and PET, optical imaging offers greater accessibility and ease of use. Its versatility across oncology, neurology, and cardiovascular research drives its strong market presence.

preclinical-imaging-market-insights-and-key-trends

Region-wise Analysis

North America Preclinical Imaging Market Trends

North America is anticipated to dominate the global market in 2025 with 35.5% value share. This dominance is driven by region’s strong ecosystem of dedicated preclinical CROs, advanced imaging centres, and robust academic-industry collaborations. The early adoption of cutting-edge imaging modalities further strengthens the market position.

In September 2023, U.S.-based Revvity expanded its preclinical imaging portfolio by introducing advanced systems such as IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and the Vega preclinical ultrasound system, enabling breakthrough discoveries.

Additionally, in May 2025, the installation of the world’s first high-field 7T SPECT/MR tri-modality system at Houston Methodist by MR Solutions highlights ongoing innovation. These advancements underscore the leadership and dynamic growth of the U.S. preclinical imaging market within North America.

Europe Preclinical Imaging Market Trends

Europe market is rapidly advancing, supported by strong collaborative networks and cutting-edge research infrastructure. The region benefits from initiatives that bridge imaging across scales and communities, fostering innovation from molecular to human applications.

Notably, in 2018, MedUni Vienna participated in the EU COST COMULIS project, enhancing biological and preclinical imaging capabilities. In 2020, University College Dublin became a key partner in establishing Ireland’s first national preclinical imaging center, strengthening regional expertise.

Looking ahead, the German Research Foundation (DFG) announced significant funding in 2025 to support interdisciplinary imaging research, emphasizing integration across modalities and scales. These collaborative efforts and investments position Europe as a dynamic hub for preclinical imaging innovation, driving both academic and clinical research forward.

Asia Pacific Preclinical Imaging Market Trends

Asia Pacific is experiencing robust growth, driven by increasing investments in biomedical research and expanding healthcare infrastructure across the region. In India, government initiatives and emphasis on academic research has boosted the adoption of advanced imaging technologies, supporting drug discovery and development efforts. According to recent studies, India’s focus on preclinical imaging is strengthening due to rising demand for non-invasive diagnostic tools in disease modelling and therapy evaluation.

In China, collaborations such as the recent partnership between HKSH Medical Group and global healthcare leaders are accelerating innovation in imaging technologies, enhancing access and capabilities in preclinical research. Furthermore, China’s strategic investments in imaging infrastructure and biotechnology are positioning it as a major hub for preclinical imaging advancements. These developments underscore Asia-Pacific’s emergence as a key player in the global preclinical imaging market.

Request Free sampleRequest Free sample

Competitive Landscape

The competitive landscape of global preclinical imaging market is marked by continuous innovation and strategic collaborations. Leading companies are focusing on advancing imaging technologies to enhance resolution, versatility, and application-specific capabilities in preclinical research.

Key Industry Developments

In April 2025, Revvity, Inc., introduced the VivoJect™ Image-Guided Injection System at the AACR Annual Meeting in Chicago. This system, paired with the Vega™ automated preclinical ultrasound system, enhances real-time imaging and precise injections for high-throughput in vivo studies. It streamlines workflows in tumor model development, targeted drug delivery, gene therapy, stem cell research, and cardiac studies
In July 2024, MILabs upgraded their U-CT system for in vivo imaging of COVID-19 animal models, providing ultra-high-resolution, non-invasive lung imaging that enables precise localization of disease processes in small animals.
In February 2024, Bruker acquired Spectral Instruments Imaging LLC, enhancing the product portfolio of its BioSpin Preclinical Imaging (PCI) division and expanding its range of preclinical solutions for disease research.
In May 2023, Scintica partnered with BIOEMTECH to broaden global access to preclinical instruments for researchers, facilitating in vivo screening of SPECT and PET isotopes, while also enabling seamless integration with optical imaging techniques such as fluorescence, bioluminescence, and Cherenkov luminescence.

Companies Covered in Preclinical Imaging Market

Bruker
Siemens Healthcare Private Limited
Revvity
FUJIFILM VisualSonics, Inc.
Scintica
MILabs B.V.
United Imaging Healthcare Co., Ltd.
Mediso Ltd.
Aspect Imaging Ltd.
Inviscan Imaging Systems
TriFoil Imaging
Southern Scientific Ltd.
Iconeus
MR Solutions
BioPAL, Inc.
Viscover

Frequently Asked Questions

The global market is set to reach US$ 4.5 Bn in 2025.

The market is projected to record a CAGR of 4.6% during the forecast period from 2025 to 2032.

Demand for preclinical imaging are growing globally due to increasing demand for advanced, non-invasive technologies to accelerate drug discovery and disease research.

Bruker, Revvity, FUJIFILM VisualSonics, Inc., Siemens Healthcare Private Limited, and United Imaging Healthcare Co., Ltd., are a few leading players.

North America is projected to dominate the global market in 2025.

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Executive Summary
1. Global Preclinical Imaging Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Product Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. Key Deals and Mergers
5. PESTLE Analysis
6. Porter’s Five Force Analysis
Price Analysis, 2024A
1. Key Highlights
2. Key Factors Impacting Product Prices
3. Pricing Analysis, By Product
4. Regional Prices and Product Preferences
Global Preclinical Imaging Market Outlook
1. Key Highlights
  1. Market Volume (Units) Projections
  2. Market Size (US$ Mn) and Y-o-Y Growth
  3. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2019 - 2024
  2. Market Size (US$ Mn) Analysis and Forecast, 2025 - 2032
3. Global Preclinical Imaging Market Outlook: Product
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019 - 2024
  3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
    1. Imaging Systems
    2. Reagents
    3. Software & Services
  4. Market Attractiveness Analysis: Product
4. Global Preclinical Imaging Market Outlook: Modality
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Modality, 2019 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Modality, 2025 - 2032
    1. Optical Imaging
    2. Nuclear Molecular Imaging
    3. Micro MRI
    4. Micro Ultrasound
    5. Micro CT
    6. Photoacoustic Tomography (PAT)
    7. Magnetic Particle Imaging
    8. Others
  4. Market Attractiveness Analysis: Modality
5. Global Preclinical Imaging Market Outlook: Application
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    1. Research & Development
    2. Drug Discovery & Development
  4. Market Attractiveness Analysis: Application
6. Global Preclinical Imaging Market Outlook: End User
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
    1. Pharmaceutical and Biotech Companies
    2. Academic and Research Institutes
    3. Imaging Centers
    4. Others
  4. Market Attractiveness Analysis: End User
Global Preclinical Imaging Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Preclinical Imaging Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Modality
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. U.S.
  2. Canada
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. Imaging Systems
  2. Reagents
  3. Software & Services
5. Market Size (US$ Mn) Analysis and Forecast, By Modality, 2025 - 2032
  1. Optical Imaging
  2. Nuclear Molecular Imaging
  3. Micro MRI
  4. Micro Ultrasound
  5. Micro CT
  6. Photoacoustic Tomography (PAT)
  7. Magnetic Particle Imaging
  8. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Research & Development
  2. Drug Discovery & Development
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Pharmaceutical and Biotech Companies
  2. Academic and Research Institutes
  3. Imaging Centers
  4. Others
8. Market Attractiveness Analysis
Europe Preclinical Imaging Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Modality
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. Imaging Systems
  2. Reagents
  3. Software & Services
5. Market Size (US$ Mn) Analysis and Forecast, By Modality, 2025 - 2032
  1. Optical Imaging
  2. Nuclear Molecular Imaging
  3. Micro MRI
  4. Micro Ultrasound
  5. Micro CT
  6. Photoacoustic Tomography (PAT)
  7. Magnetic Particle Imaging
  8. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Research & Development
  2. Drug Discovery & Development
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Pharmaceutical and Biotech Companies
  2. Academic and Research Institutes
  3. Imaging Centers
  4. Others
8. Market Attractiveness Analysis
East Asia Preclinical Imaging Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Modality
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. Imaging Systems
  2. Reagents
  3. Software & Services
5. Market Size (US$ Mn) Analysis and Forecast, By Modality, 2025 - 2032
  1. Optical Imaging
  2. Nuclear Molecular Imaging
  3. Micro MRI
  4. Micro Ultrasound
  5. Micro CT
  6. Photoacoustic Tomography (PAT)
  7. Magnetic Particle Imaging
  8. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Research & Development
  2. Drug Discovery & Development
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Pharmaceutical and Biotech Companies
  2. Academic and Research Institutes
  3. Imaging Centers
  4. Others
8. Market Attractiveness Analysis
South Asia & Oceania Preclinical Imaging Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Modality
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. Imaging Systems
  2. Reagents
  3. Software & Services
5. Market Size (US$ Mn) Analysis and Forecast, By Modality, 2025 - 2032
  1. Optical Imaging
  2. Nuclear Molecular Imaging
  3. Micro MRI
  4. Micro Ultrasound
  5. Micro CT
  6. Photoacoustic Tomography (PAT)
  7. Magnetic Particle Imaging
  8. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Research & Development
  2. Drug Discovery & Development
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Pharmaceutical and Biotech Companies
  2. Academic and Research Institutes
  3. Imaging Centers
  4. Others
8. Market Attractiveness Analysis
Latin America Preclinical Imaging Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Modality
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. Imaging Systems
  2. Reagents
  3. Software & Services
5. Market Size (US$ Mn) Analysis and Forecast, By Modality, 2025 - 2032
  1. Optical Imaging
  2. Nuclear Molecular Imaging
  3. Micro MRI
  4. Micro Ultrasound
  5. Micro CT
  6. Photoacoustic Tomography (PAT)
  7. Magnetic Particle Imaging
  8. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Research & Development
  2. Drug Discovery & Development
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Pharmaceutical and Biotech Companies
  2. Academic and Research Institutes
  3. Imaging Centers
  4. Others
8. Market Attractiveness Analysis
Middle East & Africa Preclinical Imaging Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Modality
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. Imaging Systems
  2. Reagents
  3. Software & Services
5. Market Size (US$ Mn) Analysis and Forecast, By Modality, 2025 - 2032
  1. Optical Imaging
  2. Nuclear Molecular Imaging
  3. Micro MRI
  4. Micro Ultrasound
  5. Micro CT
  6. Photoacoustic Tomography (PAT)
  7. Magnetic Particle Imaging
  8. Others
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Research & Development
  2. Drug Discovery & Development
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Pharmaceutical and Biotech Companies
  2. Academic and Research Institutes
  3. Imaging Centers
  4. Others
8. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Bruker
    1. Overview
    2. Segments and Product
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Siemens Healthcare Private Limited
  3. Revvity
  4. FUJIFILM VisualSonics, Inc.
  5. Scintica
  6. MILabs B.V.
  7. United Imaging Healthcare Co., Ltd.
  8. Mediso Ltd.
  9. Aspect Imaging Ltd.
  10. Inviscan Imaging Systems
  11. TriFoil Imaging
  12. Southern Scientific Ltd.
  13. Iconeus
  14. MR Solutions
  15. BioPAL, Inc.
  16. Viscover
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Global Market Attribute	Key Insights
Preclinical Imaging Market Size (2025E)	US$ 4.5 Bn
Market Value Forecast (2032F)	US$ 6.2 Bn
Projected Growth (CAGR 2025 to 2032)	4.6%
Historical Market Growth (CAGR 2019 to 2024)	4.0%

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Mn/Bn Volume: Units
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	Product Modality Application End-user Region
Competitive Analysis	Bruker Siemens Healthcare Private Limited Revvity FUJIFILM VisualSonics, Inc. Scintica MILabs B.V. United Imaging Healthcare Co., Ltd. Mediso Ltd. Aspect Imaging Ltd. Inviscan Imaging Systems TriFoil Imaging Southern Scientific Ltd. Iconeus MR Solutions BioPAL, Inc. Viscover
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis & Technology Roadmap Future Opportunities and Revenue Pockets Market Analysis Tools
Customization and Pricing	Available upon request

Global Market Attribute	Key Insights
Preclinical Imaging Market Size (2025E)	US$ 4.5 Bn
Market Value Forecast (2032F)	US$ 6.2 Bn
Projected Growth (CAGR 2025 to 2032)	4.6%
Historical Market Growth (CAGR 2019 to 2024)	4.0%

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Mn/Bn Volume: Units
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	Product Modality Application End-user Region
Competitive Analysis	Bruker Siemens Healthcare Private Limited Revvity FUJIFILM VisualSonics, Inc. Scintica MILabs B.V. United Imaging Healthcare Co., Ltd. Mediso Ltd. Aspect Imaging Ltd. Inviscan Imaging Systems TriFoil Imaging Southern Scientific Ltd. Iconeus MR Solutions BioPAL, Inc. Viscover
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis & Technology Roadmap Future Opportunities and Revenue Pockets Market Analysis Tools
Customization and Pricing	Available upon request

Preclinical Imaging Market Size, Share, Growth, and Regional Forecast, 2025 - 2032

Preclinical Imaging Market By Product (Imaging Systems, Reagents, Software and Services), Modality, Application, End-user and Regional Analysis for 2025 - 2032